FDA clears smart inhaler cap from Cognita Labs
Known as CapMedic, the device signals patients to help them use inhalers correctly. Developers hope the feedback mechanism distinguishes the device from other smart inhalers.
Cold Genesys secures $22M Series C round for oncolytic virus in bladder cancer
The company's lead product candidate, CG0070, has completed a Phase II study and will be tested in another trial, combined with Merck's Keytruda.
presented by
Everything You Need to Know About Who Accredits Health Plans for Mental Health Parity Compliance
Who accredits health plans for mental health parity compliance? Learn about the only organization that offers this program to ensure your members get equitable care.
Agendia took gamble on FDA approval for breast-cancer test
Irvine-based Agendia complains that while it spent huge amounts of time, energy and resources to gain formal approval from U.S. Food and Drug Administration for its breast-cancer test, its chief rival, Genomic Health Inc., has chosen to bypass federal ...